Clinical Trial Update: Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating first-line chemotherapy with or without cetuximab for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Velindre NHS Trust | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN